Results 21 to 30 of about 136,697 (349)
Co-prevalence of Substance Use Disorders and Common AxisⅠDisorders in Yunnan's Drug Users [PDF]
Zhongguo quanke yixue, 2022 Background Mental disorders in drug users have received increasing attention. However, there are no any epidemiologic data available in regard to substance use disorders (SUD) and other mental disorders in drug users in Yunnan, one region that is hit ...
ZHANG Guanbai, ZHENG Ling, YANG Liping, ZHOU Qin, WANG Fei, HE Liangze, CHENG Xuan, CHA Li, LI Xinyue
doaj +1 more source
Methadone for Opioid Use Treatment during Pregnancy: Trends in Postpartum Dose Adjustments
American Journal of Perinatology Reports, 2020 Objective This study examines methadone dose adjustment postpartum. Methods A retrospective study of women with methadone for opioid use treatment (OUT) during pregnancy was performed.
Clara Ward, Carl W. Christensen
doaj +1 more source
Single high-dose buprenorphine for opioid craving during withdrawal. [PDF]
, 2018 BackgroundOpioid use disorder is one of the most prevalent addiction problems worldwide. Buprenorphine is used as a medication to treat this disorder, but in countries where buprenorphine is unavailable in combination with naloxone, diversion can be a ...
Ahmadi, Jamshid +3 more
core +2 more sources
SnapShot: Neurobiology of opioid use disorder [PDF]
Cell, 2021 The use of opioid drugs and related overdose deaths, which rose to epidemic proportions over the past decade, have been exacerbated by the COVID pandemic, a time of great uncertainty and isolation. Much is known about opioid pharmacology and related neural circuits that, combined with novel emerging neurobiological insights, can help guide new ...
Randall J, Ellis +3 more
openaire +2 more sources
Medication Treatment of Opioid Use Disorder [PDF]
Biological Psychiatry, 2020 Opioid use disorder (OUD) is a chronic, relapsing condition, often associated with legal, interpersonal, and employment problems. Medications demonstrated to be effective for OUD are methadone (a full opioid agonist), buprenorphine (a partial agonist), and naltrexone (an opioid antagonist).
James Bell, John Strang
openaire +4 more sources
Comorbid opioid use is undertreated among forensic patients with schizophrenia
Substance Abuse Treatment, Prevention, and Policy, 2018 Background Substance use disorders are associated with poorer clinical outcomes in patients with schizophrenia. There is no specific treatment for amphetamine or cannabis use disorder, but methadone and buprenorphine are used as replacement therapy in ...
Kristiina Kivimies +3 more
doaj +1 more source
Addiction Science & Clinical Practice, 2019 Background The study examined the association of the Affordable Care Act’s 2014 Medicaid expansion on the use of psychosocial services and pharmacotherapies for opioid use disorders among Oregon Medicaid recipients.
Dennis McCarty +3 more
doaj +1 more source
Addiction Science & Clinical Practice, 2022 Background Residential treatment is a common approach for treating opioid use disorder (OUD), however, few studies have directly compared it to outpatient treatment.
Daniel M. Hartung +11 more
doaj +1 more source
Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
Drug and Alcohol Dependence Reports, 2022 Background: Patients with opioid use disorder (OUD) have high hospital admission rates. Hospitalists, clinicians that work in inpatient medical settings, may have a unique opportunity to intervene on behalf of these patients, yet their experience with ...
Megan K Reed +5 more
doaj +1 more source
The Experience of Intimate Partner Violence Among Pregnant Women Seeking Treatment for Opioid Use Disorder [PDF]
, 2020 Introduction: Intimate partner violence (IPV) is a major health issue among those with substance use disorder. A history of partner violence is associated with increased health problems and less improvement in treatment. The perinatal period is a time of
Abatemarco, PhD, MSW, Diane +1 more
core +1 more source